Shenzhen Sixth People's Hospital
7
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
29%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
Role: collaborator
CT Image-assisted Detection Software for Focal Liver Lesions
Role: collaborator
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
Role: collaborator
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
Role: collaborator
Clinical Evaluation of COPD Butler in Patient Home Management
Role: collaborator
Scalp Acupuncture Combined rTMS on Brain White Matter Microstructure of Hemiplegic Patients With Stroke
Role: lead
The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis
Role: collaborator
All 7 trials loaded